Please ensure Javascript is enabled for purposes of website accessibility


Nasdaq Global Select

Epizyme Stock Quote
$8.59 -$0.22 -2.5%
Price as of June 18, 2021, 4:00 p.m. ET View Interactive EPZM Charts

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

Interactive Chart

News & Analysis: Epizyme


Market Moves


Here's Why Epizyme Lost 27.6% in March

Investors were looking forward to the drug company's transition to commercial operations, but the coronavirus pandemic could delay the maturation process.